logo

For the Inventor, By the Inventor

Chapel Hill, NC, United States of America

Soman N Abraham

This inventor holds 8 USPTO granted patents and 2 published patent applications. Top assignee: Duke University. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soman N Abraham. Retrieved from https://idiyas.com/inventor/soman-n-abraham

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 87.5

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal8 out of 2,085 
 
Duke University
 patents

Years Active: 2011-2025

Loading Chart...
8 patents (USPTO):Explore Patents
1. 12491237 - VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS (2025-12-09),
2. 10668059 - Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage (2020-06-02),
3. 10245319 - Lymph node-targeting nanoparticles (2019-04-02),
4. 9782475 - Method of treating food allergies by administering a nanoparticle comprising heparin and chitosan encapsulating IL-12 (2017-10-10),
5. 9730921 - Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage (2017-08-15),
6. 9301999 - Peptide, adjuvants, vaccines, and methods of use (2016-04-05),
7. 8802076 - Compositions and methods for modulating an immune response (2014-08-12),
8. 8076059 - Adjuvant capable of specifically activating the adaptive immune response (2011-12-13),

Title: Innovations and Contributions of Soman N Abraham

Introduction

Soman N Abraham is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biomedical research, particularly in the areas of immunology and infectious diseases. With a total of seven patents to his name, Abraham's work has the potential to impact medical treatments and therapies.

Latest Patents

Among his latest patents is a method for the prevention and treatment of mast cell-induced vascular leakage. This invention focuses on diagnosing and treating infectious diseases characterized by hemorrhaging or pathological vascular leakage. Another notable patent involves lymph node-targeting nanoparticles, which comprise heparin, chitosan, and at least one immunomodulatory agent, such as a cytokine. This innovation provides methods for making nanoparticles and modulating immune responses through co-administration with antigens or vaccines.

Career Highlights

Soman N Abraham is affiliated with Duke University, where he conducts research and develops his innovative ideas. His work has garnered attention for its potential applications in treating various medical conditions.

Collaborations

Abraham has collaborated with notable colleagues, including Herman F Staats and Ashley L St John, who contribute to his research endeavors.

Conclusion

Soman N Abraham's innovative work and patents reflect his commitment to advancing medical science and improving treatment options for patients. His contributions are significant in the ongoing fight against infectious diseases and related health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…